These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1532644)

  • 1. [Effect of radioactive iodine treatment on TSH receptor antibodies in Basedow's disease].
    Heshmati HM; Dagousset F; Izembart M; Clerc J
    Presse Med; 1992 Feb; 21(6):268. PubMed ID: 1532644
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of thyroid size and TSH receptor antibody (TRAb) determinations in predicting the effectiveness of tiamazole and I-131 treatment for Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):242-7. PubMed ID: 15314993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
    Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
    Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of the treatment of Basedow's disease with iodine-131].
    Rivière J; Roger P; Nogue F; Emperaire JC; Latapie JL; Reboul J; Blanquet P
    Ann Endocrinol (Paris); 1974; 35(1):38-9. PubMed ID: 4479600
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperthyroidism.
    van Haeften TW
    Lancet; 2003 Nov; 362(9395):1584. PubMed ID: 14615126
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine].
    Schrub JC; Nouel JP; Brunelle P; Segond G; Courtois H; Poirier A
    Nouv Presse Med; 1976 May; 5(21):1346-8. PubMed ID: 778789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of anti-TSH receptor antibodies in Basedow's disease treated with carbimazole].
    Duprey J; Izembart M; Vallée G; Goupil M
    Ann Med Interne (Paris); 1986; 137(7):555-8. PubMed ID: 3813296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and quantitative impact of protective glucocorticoid therapy on the effective 131I half-life in radioiodine therapy for Graves disease.
    Hautzel H; Pisar E; Yazdan-Doust N; Schott M; Beu M; Müller HW
    J Nucl Med; 2010 Dec; 51(12):1917-22. PubMed ID: 21078788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of Basedow's disease in early pregnancy with iodine radioisotopes].
    Gavallér I
    Orv Hetil; 1974 May; 115(20):1169-71. PubMed ID: 4406530
    [No Abstract]   [Full Text] [Related]  

  • 11. [131-I treatment of Basedow's disease].
    Hara M
    Horumon To Rinsho; 1974 Feb; 22(2):263-8. PubMed ID: 4407981
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioiodine therapy for hyperthyroidism.
    Villagelin D; Santos RB; Romaldini JH
    N Engl J Med; 2011 May; 364(20):1978; author reply 1978-9. PubMed ID: 21591960
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Basedow's disease with 131-I combined with lithium].
    Sato K
    Kaku Igaku; 1983 Mar; 20(2):171-7. PubMed ID: 6688446
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proceedings: Results of reduction of the initial dosage of 131 I in the treatment of Basedow's disease].
    Mori T; Konishi J; Ikekubo K; Morita R; Sakurami T
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):423. PubMed ID: 4480298
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of thyrostatic treatment on circulating thyrotropin-receptor antibodies in Basedow's disease].
    Lozanov B; Kirilov G; Ivanova R; Khubaveshki S
    Vutr Boles; 1990; 29(3):79-84. PubMed ID: 1704667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of radioiodine therapy on the serum calcitonin level in patients with Basedow's disease].
    Földes J; Bános C; Krasznai I; Petrányi G; Steczek K
    Orv Hetil; 1984 Feb; 125(7):383-6. PubMed ID: 6546614
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocytes resided in the thyroid are the main source of TSH-receptor antibodies in Basedow's-Graves' disease?
    Leövey A; Nagy E; Balazs G; Bako G
    Exp Clin Endocrinol; 1992; 99(3):147-50. PubMed ID: 1526264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].
    Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J
    Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term surveillance of patients treated for Basedow's disease].
    Chavrier B; Berthezene F; Mornex R
    Ann Endocrinol (Paris); 1974; 35(1):72-3. PubMed ID: 4479479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.